Duolin Forte Rotacap (Levosalbutamol / Ipratropium)
Duolin Forte Rotacap is a combination respiratory medication used for the treatment and management of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions associated with airway obstruction. It contains Levosalbutamol, a bronchodilator that relaxes the airway muscles, and Ipratropium, an anticholinergic agent that helps widen the airways by blocking nerve signals in the lungs.
This dual-action therapy helps improve breathing by opening the airways and reducing bronchospasm, providing relief from symptoms such as wheezing, coughing, chest tightness, and shortness of breath. Duolin Forte Rotacap is designed to be used with a Rotahaler device, allowing the medication to be inhaled directly into the lungs for effective respiratory relief.
TabExports supplies Duolin Forte Rotacap (Levosalbutamol / Ipratropium) to international pharmaceutical markets with reliable export services and consistent product quality.
Key Benefits
-
Helps open narrowed airways
-
Provides relief from breathing difficulties
-
Reduces wheezing and chest tightness
-
Combines two bronchodilators for enhanced effectiveness
-
Supports better lung function
Uses
-
Asthma management
-
Chronic obstructive pulmonary disease (COPD)
-
Bronchospasm relief
-
Other respiratory breathing disorders
Active Ingredients
-
Levosalbutamol
-
Ipratropium
Global Supply by TabExports
TabExports exports Duolin Forte Rotacap (Levosalbutamol / Ipratropium) to international markets including the United States of America, the United Kingdom, France, Australia, and Thailand. We ensure high-quality pharmaceutical products with secure packaging and reliable global delivery.
Storage Instructions
Store in a cool and dry place away from direct sunlight. Keep the rotacaps in their original packaging and out of reach of children.
Disclaimer
Use this medication only as prescribed by a healthcare professional. Do not exceed the recommended dosage without medical advice.





Reviews
There are no reviews yet.